902
Views
121
CrossRef citations to date
0
Altmetric
Inflammatory Bowel Disease

Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: A randomized, controlled, evaluator-blind, multicentre study

, PhD , MD, , , , , , , , & show all
Pages 838-845 | Received 19 Dec 2008, Published online: 21 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (13)

Gaetano Bergamaschi, Flavio Caprioli, Marco Vincenzo Lenti, Luca Elli, Franco Radaelli, Emanuele Rondonotti, Caterina Mengoli, Emanuela Miceli, Chiara Ricci, Sandro Ardizzone, Maurizio Vecchi & Antonio Di Sabatino. (2022) Pathophysiology and therapeutic management of anemia in gastrointestinal disorders. Expert Review of Gastroenterology & Hepatology 16:7, pages 625-637.
Read now
Aysegül Aksan, Ian L P Beales, Garth Baxter, Antonio Ramirez de Arellano, Simona Gavata, William J Valentine & Barnaby Hunt. (2021) Evaluation of the Cost-Effectiveness of Iron Formulations for the Treatment of Iron Deficiency Anaemia in Patients with Inflammatory Bowel Disease in the UK. ClinicoEconomics and Outcomes Research 13, pages 541-552.
Read now
Sara Valério de Azevedo, Catarina Maltez & Ana Isabel Lopes. (2017) Pediatric Crohn's disease, iron deficiency anemia and intravenous iron treatment: a follow-up study. Scandinavian Journal of Gastroenterology 52:1, pages 29-33.
Read now
Monica Varcher, Sofia Zisimopoulou, Olivia Braillard, Bernard Favrat & Noëlle Junod Perron. (2016) Iron deficiency intravenous substitution in a Swiss academic primary care division: analysis of practices. International Journal of General Medicine 9, pages 221-227.
Read now
David C Ford, Naomi V Dahl, William E Strauss, Charles F Barish, David J Hetzel, Kristine Bernard, Zhu Li & Lee F Allen. (2016) Ferumoxytol versus placebo in iron deficiency anemia: efficacy, safety, and quality of life in patients with gastrointestinal disorders. Clinical and Experimental Gastroenterology 9, pages 151-162.
Read now
Andreas Stallmach & Carsten Büning. (2015) Ferric maltol (ST10): a novel oral iron supplement for the treatment of iron deficiency anemia in inflammatory bowel disease. Expert Opinion on Pharmacotherapy 16:18, pages 2859-2867.
Read now
. (2015) 3rd Mediterranean Multidisciplinary Course on Iron Anemia. Expert Review of Hematology 8:sup1, pages S1-S32.
Read now
Neil D Goldberg. (2013) Iron deficiency anemia in patients with inflammatory bowel disease. Clinical and Experimental Gastroenterology 6, pages 61-70.
Read now
Ragnar Befrits, Ola Wikman, Lars Blomquist, Henrik Hjortswang, Per Hammarlund, Antal Bajor, Daniel Klintman & Håkan Blom. (2013) Anemia and iron deficiency in inflammatory bowel disease: an open, prospective, observational study on diagnosis, treatment with ferric carboxymaltose and quality of life. Scandinavian Journal of Gastroenterology 48:9, pages 1027-1032.
Read now
Barrie D Keeler, Jonathan Krell, Austin G Acheson, Matthew J Brookes, Justin Stebbing & Adam E Frampton. (2012) Is there a role for intravenous iron therapy in patients undergoing colorectal cancer resection?. Expert Review of Anticancer Therapy 12:11, pages 1407-1412.
Read now
Palle Bager, Ragnar Befrits, Ola Wikman, Stefan Lindgren, Bjørn Moum, Henrik Hjortswang & Jens F. Dahlerup. (2011) The prevalence of anemia and iron deficiency in IBD outpatients in Scandinavia. Scandinavian Journal of Gastroenterology 46:3, pages 304-309.
Read now

Articles from other publishers (108)

Massimo Martinelli, Maria Teresa Fioretti, Marina Aloi, Patrizia Alvisi, Serena Arrigo, Claudia Banzato, Matteo Bramuzzo, Angelo Campanozzi, Fortunata Civitelli, Daniela Knafelz, Paolo Lionetti, Antonio Marseglia, Francesca Musto, Lorenzo Norsa, Giuseppe Palumbo, Sara Renzo, Claudio Romano, Naire Sansotta, Caterina Strisciuglio & Erasmo Miele. (2024) Diagnosis and management of anemia in pediatric inflammatory bowel diseases: Clinical practice guidelines on behalf of the SIGENP IBD Working group. Digestive and Liver Disease.
Crossref
Hannah Gordon, Johan Burisch, Pierre Ellul, Konstantinos Karmiris, Konstantinos Katsanos, Mariangela Allocca, Giorgos Bamias, Manuel Barreiro-de Acosta, Tasanee Braithwaite, Thomas Greuter, Catherine Harwood, Pascal Juillerat, Triana Lobaton, Ulf Müller-Ladner, Nurulamin Noor, Gianluca Pellino, Edoardo Savarino, Christoph Schramm, Alessandra Soriano, Jürgen Michael Stein, Mathieu Uzzan, Patrick F van Rheenen, Stephan R Vavricka, Maurizio Vecchi, Stephane Zuily & Torsten Kucharzik. (2024) ECCO Guidelines on Extraintestinal Manifestations in Inflammatory Bowel Disease. Journal of Crohn's and Colitis 18:1, pages 1-37.
Crossref
Arunchai Chang, Manus Rugivarodom, Nuttanit Pungpipattrakul, Keerati Akarapatima, Komsai Suwanno, Attapon Rattanasupar, Bancha Ovartlarnporn & Varayu Prachayakul. (2023) Role of oral iron supplementation for anemia secondary to acute nonvariceal upper gastrointestinal bleeding: a randomized controlled trial. Journal of Gastroenterology and Hepatology 38:8, pages 1283-1291.
Crossref
Richard D. Horniblow, Prachi Pathak, Maryam Eshrati, Gladys O. Latunde-Dada & Chris Tselepis. (2023) Intestinal iron bio-accessibility changes by Lignin and the subsequent impact on cell metabolism and intestinal microbiome communities. Food & Function 14:8, pages 3673-3685.
Crossref
Motoi Sugimura, Yasuyoshi Ohtani, Soichiro Tamai, Umi Kishimoto & Naoki Ito. (2023) Ferric derisomaltose for the treatment of iron deficiency anemia with postpartum hemorrhage: Results of a single‐arm, open‐label, phase 3 study in Japan. Journal of Obstetrics and Gynaecology Research 49:3, pages 946-955.
Crossref
Ajay K. Jain, Sandip Vare, Shohini Sircar, Amit D. Joshi & Deepika Jain. (2022) Impact of iron deficiency anemia on quality of life in patients with ulcerative colitis. Advances in Digestive Medicine 10:1, pages 15-20.
Crossref
Laura A. Maas, Mahesh Krishna & Alyssa M. Parian. (2022) Ironing It All Out: A Comprehensive Review of Iron Deficiency Anemia in Inflammatory Bowel Disease Patients. Digestive Diseases and Sciences 68:2, pages 357-369.
Crossref
Johannes M. M. Boots & Rogier A. M. Quax. (2022) High-Dose Intravenous Iron with Either Ferric Carboxymaltose or Ferric Derisomaltose: A Benefit-Risk Assessment. Drug Safety 45:10, pages 1019-1036.
Crossref
Stefanie Howaldt, Eugeni Domènech, Nicholas Martinez, Carsten Schmidt & Bernd Bokemeyer. (2022) Long-Term Effectiveness of Oral Ferric Maltol vs Intravenous Ferric Carboxymaltose for the Treatment of Iron-Deficiency Anemia in Patients With Inflammatory Bowel Disease: A Randomized Controlled Noninferiority Trial. Inflammatory Bowel Diseases 28:3, pages 373-384.
Crossref
Rocco SPAGNUOLO, Ludovico ABENAVOLI, Tiziana LARUSSA, Chiara IANNELLI, Rinaldo PELLICANO, Sharmila FAGOONEE, Patrizia DOLDO & Francesco LUZZA. (2022) Safety profile of intravenous iron in inflammatory bowel disease: an up-to-date overview. Minerva Gastroenterology 68:1.
Crossref
Andreas Sturm, Raja Atreya, Dominik Bettenworth, Bernd Bokemeyer, Axel Dignaß, Robert Ehehalt, Christoph Germer, Philip C. Grunert, Ulf Helwig, Klaus Herrlinger, Peter Kienle, Martin E. Kreis, Torsten Kucharzik, Jost Langhorst, Christian Maaser, Johann Ockenga, Claudia Ott, Britta Siegmund, Sebastian Zeißig & Andreas Stallmach. (2022) Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – August 2021 – AWMF-Registernummer: 021-004. Zeitschrift für Gastroenterologie 60:03, pages 332-418.
Crossref
Helena Tiekou Lorinczova, Gulshanara Begum, Lina Temouri, Derek Renshaw & Mohammed Gulrez Zariwala. (2022) Co-Administration of Iron and Bioavailable Curcumin Reduces Levels of Systemic Markers of Inflammation and Oxidative Stress in a Placebo-Controlled Randomised Study. Nutrients 14:3, pages 712.
Crossref
Hoda Shokri & Ihab Ali. (2022) Intravenous iron supplementation treats anemia and reduces blood transfusion requirements in patients undergoing coronary artery bypass grafting—A prospective randomized trial. Annals of Cardiac Anaesthesia 25:2, pages 141.
Crossref
Johannes Stallhofer, Lisa VeithJulia DiegelmannPhilipp ProbstStephan BrandFabian SchnitzlerTorsten OlszakHelga TörökJulia MayerleAndreas StallmachFlorian Beigel. (2022) Iron Deficiency in Inflammatory Bowel Disease Is Associated With Low Levels of Vitamin D Modulating Serum Hepcidin and Intestinal Ceruloplasmin Expression. Clinical and Translational Gastroenterology 13:1, pages e00450.
Crossref
. 2022. Arzneimitteltherapie in der Palliativmedizin. Arzneimitteltherapie in der Palliativmedizin 901 932 .
Aysegül Aksan, Alain Schoepfer, Pascal Juillerat, Stephan Vavricka, Miguel Bettencourt, Antonio Ramirez de Arellano, Simona Gavata, Neige Morin, William J. Valentine & Barnaby Hunt. (2021) A Response to: Letter to the Editor Regarding ‘Iron Formulations for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease: A Cost-Effectiveness Analysis in Switzerland’. Advances in Therapy 39:1, pages 815-821.
Crossref
Jonathon Snook, Neeraj Bhala, Ian L P Beales, David Cannings, Chris Kightley, Robert PH Logan, D Mark Pritchard, Reena Sidhu, Sue Surgenor, Wayne Thomas, Ajay M Verma & Andrew F Goddard. (2021) British Society of Gastroenterology guidelines for the management of iron deficiency anaemia in adults. Gut 70:11, pages 2030-2051.
Crossref
Akshay A. Shah, Killian Donovan, Claire Seeley, Edward A. DicksonAntony J. R. Palmer, Carolyn Doree, Susan Brunskill, Jack Reid, Austin G. AchesonAnita Sugavanam, Edward Litton & Simon J. Stanworth. (2021) Risk of Infection Associated With Administration of Intravenous Iron. JAMA Network Open 4:11, pages e2133935.
Crossref
Lorenzo Bertani, Domenico Tricò, Federico Zanzi, Giovanni Baiano Svizzero, Francesca Coppini, Nicola de Bortoli, Massimo Bellini, Luca Antonioli, Corrado Blandizzi & Santino Marchi. (2021) Oral Sucrosomial Iron Is as Effective as Intravenous Ferric Carboxy-Maltose in Treating Anemia in Patients with Ulcerative Colitis. Nutrients 13:2, pages 608.
Crossref
Mustafa TEKİN, Navdar Doğuş UZUN & Fulya UZUN. (2021) Evaluation of ferric carboxymaltose treatment efficacy in women with postpartum iron deficiency anemiaDoğum sonrası demir eksikliği anemisi olan kadınlarda ferrik karboksimaltoz tedavisinin etkinliğinin değerlendirilmesi. Journal of Health Sciences and Medicine 4:1, pages 23-27.
Crossref
Morris Gordon, Vassiliki Sinopoulou, Zipporah Iheozor-Ejiofor, Tariq Iqbal, Patrick Allen, Sami Hoque, Jaina Engineer & Anthony K Akobeng. (2021) Interventions for treating iron deficiency anaemia in inflammatory bowel disease. Cochrane Database of Systematic Reviews 2021:1.
Crossref
Aysegül Aksan, Alain Schoepfer, Pascal Juillerat, Stephan Vavricka, Miguel Bettencourt, Antonio Ramirez de Arellano, Simona Gavata, Neige Morin, William J. Valentine & Barnaby Hunt. (2020) Iron Formulations for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease: A Cost-Effectiveness Analysis in Switzerland. Advances in Therapy 38:1, pages 660-677.
Crossref
Alin Ionescu, Abhinav Sharma, Nilima Rajpal Kundnani, Alexandra Mihăilescu, Vlad Laurențiu David, Ovidiu Bedreag, Dorel Săndesc, Anca Raluca Dinu, Mihai Alexandru Săndesc, Nicolae Albulescu & Răzvan Gabriel Drăgoi. (2020) Intravenous iron infusion as an alternative to minimize blood transfusion in peri-operative patients. Scientific Reports 10:1.
Crossref
Mona Babikir, Rita Ahmad, Ashraf Soliman, Mustafa Al-Tikrity & Mohamed A Yassin. (2020) Iron-Induced Thrombocytopenia: A Mini-Review of the Literature and Suggested Mechanisms. Cureus.
Crossref
Ioannis Bellos, Maximos Frountzas & Vasilios Pergialiotis. (2020) Comparative Risk of Hypophosphatemia Following the Administration of Intravenous Iron Formulations: A Network Meta-Analysis. Transfusion Medicine Reviews 34:3, pages 188-194.
Crossref
Iain C. Macdougall, Josep Comin-Colet, Christian Breymann, Donat R. Spahn & Ioannis E. Koutroubakis. (2020) Iron Sucrose: A Wealth of Experience in Treating Iron Deficiency. Advances in Therapy 37:5, pages 1960-2002.
Crossref
I. V. Gubonina, O. B. Shchukina, N. Stuklov, T. V. Gaponova, D. I. Abdulganieva, O. V. Knyazev & N. S. Gubonina. (2020) Anemia in inflammatory bowel diseases: the approaches to its diagnosis, treatment and prevention. Almanac of Clinical Medicine 47:8, pages 721-732.
Crossref
Ana Isabel Lopes, Sara Azevedo, José Cabral, Maria Gomes Ferreira, Piedade Sande-Lemos, Ricardo Ferreira, Eunice Trindade, Rosa Lima & Henedina Antunes. (2020) Portuguese Consensus on Diagnosis, Treatment, and Management of Anemia in Pediatric Inflammatory Bowel Disease. GE - Portuguese Journal of Gastroenterology 27:4, pages 244-254.
Crossref
Stefan Amisten. (2019) Practical Management of Anaemia After a Gastrointestinal Bleed. EMJ Gastroenterology, pages 45-51.
Crossref
Istvan Danko, Marcy Weidkamp & Jens C. Eickhoff. (2019) Improvement of Health-Related Quality of Life in Children with Inflammatory Bowel Disease Receiving Routine Intravenous Iron Supplementation. The Journal of Pediatric Pharmacology and Therapeutics 24:6, pages 517-527.
Crossref
Luis Ferrer‐Barceló, Laura Sanchis Artero, Javier Sempere García‐Argüelles, Pilar Canelles Gamir, Javier P. Gisbert, Luis Manuel Ferrer‐Arranz, Ana Monzó Gallego, Lydia Plana Campos, Jose Mª Huguet Malavés, Marisol Luján Sanchis, Lucía Ruiz Sánchez, Susana Barceló Cerdá & Enrique Medina Chuliá. (2019) Randomised clinical trial: intravenous vs oral iron for the treatment of anaemia after acute gastrointestinal bleeding. Alimentary Pharmacology & Therapeutics 50:3, pages 258-268.
Crossref
Ramy Sabe, Anant Vatsayan, Amr Mahran, Ali S. Khalili, Sanjay Ahuja & Thomas J. Sferra. (2019) Safety and Efficacy of Intravenous Iron Sucrose for Iron-Deficiency Anemia in Children and Adolescents With Inflammatory Bowel Disease. Global Pediatric Health 6, pages 2333794X1987098.
Crossref
Verena Petzer, Igor Theurl & Günter Weiss. (2018) Established and Emerging Concepts to Treat Imbalances of Iron Homeostasis in Inflammatory Diseases. Pharmaceuticals 11:4, pages 135.
Crossref
Laurent Peyrin‐Biroulet, Anthony Lopez, J. R. Fraser Cummings, Axel Dignass, Trond Espen Detlie & Silvio Danese. (2018) Review article: treating‐to‐target for inflammatory bowel disease‐associated anaemia. Alimentary Pharmacology & Therapeutics 48:6, pages 610-617.
Crossref
Carl Eriksson, Ida Henriksson, Ole Brus, Yaroslava Zhulina, Nils Nyhlin, Curt Tysk, Scott Montgomery & Jonas Halfvarson. (2018) Incidence, prevalence and clinical outcome of anaemia in inflammatory bowel disease: a population‐based cohort study. Alimentary Pharmacology & Therapeutics 48:6, pages 638-645.
Crossref
Sunil Bhandari, Dora Pereira, Helen Chappell & Hal Drakesmith. (2018) Intravenous Irons: From Basic Science to Clinical Practice. Pharmaceuticals 11:3, pages 82.
Crossref
V. A. Akhmedov, M. N. Ivanyuk, G. R. Bikbavova, M. R. Ibragimova & A. R. Ibragimova. (2018) Features of the anemia at patients with Crohn’s disease. Medical Council:12, pages 78-82.
Crossref
Erasmo Miele, Raanan Shamir, Marina Aloi, Amit Assa, Christian Braegger, Jiri Bronsky, Lissy de Ridder, Johanna C. Escher, Iva Hojsak, Sanja Kolaček, Sibylle Koletzko, Arie Levine, Paolo Lionetti, Massimo Martinelli, Frank Ruemmele, Richard K. Russell, Rotem Sigall Boneh, Johan van Limbergen, Gigi Veereman & Annamaria Staiano. (2018) Nutrition in Pediatric Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition 66:4, pages 687-708.
Crossref
Dhruvan Patel, Chinmay Trivedi & Nabeel Khan. (2018) Management of Anemia in Patients with Inflammatory Bowel Disease (IBD). Current Treatment Options in Gastroenterology 16:1, pages 112-128.
Crossref
Ana Isabel Lopes & Sara Azevedo. 2018. Current Topics in Anemia. Current Topics in Anemia.
Ole Nielsen, Christoffer Soendergaard, Malene Vikner & Günter Weiss. (2018) Rational Management of Iron-Deficiency Anaemia in Inflammatory Bowel Disease. Nutrients 10:1, pages 82.
Crossref
Dorothea Niepel, Thomas Klag, Nisar P. Malek & Jan Wehkamp. (2018) Practical guidance for the management of iron deficiency in patients with inflammatory bowel disease. Therapeutic Advances in Gastroenterology 11, pages 175628481876907.
Crossref
Fermín Mearin, Ángel Lanas, Luis Bujanda, Pilar Canelles, José Cotter, Antonio Hervás, Carlos Martín de Argila, Miguel Montoro & Javier P. Gisbert. (2018) Preguntas y errores en el diagnóstico y manejo de la anemia en pacientes con hemorragia digestiva. Gastroenterología y Hepatología 41:1, pages 63-76.
Crossref
Fermín Mearin, Ángel Lanas, Luis Bujanda, Pilar Canelles, José Cotter, Antonio Hervás, Carlos Martín de Argila, Miguel Montoro & Javier P. Gisbert. (2018) Open questions and misconceptions in the diagnosis and management of anemia in patients with gastrointestinal bleeding. Gastroenterología y Hepatología (English Edition) 41:1, pages 63-76.
Crossref
. 2018. Arzneimitteltherapie in der Palliativmedizin. Arzneimitteltherapie in der Palliativmedizin 807 836 .
A. Aksan, H. Işık, H. H. Radeke, A. Dignass & J. Stein. (2017) Letter: the importance of dosing and baseline haemoglobin when establishing the relative efficacy of intravenous iron therapies—authors' reply. Alimentary Pharmacology & Therapeutics 46:7, pages 705-706.
Crossref
W. Reinisch & S. Lindgren. (2017) Letter: the importance of dosing and baseline haemoglobin when establishing the relative efficacy of intravenous iron therapies. Alimentary Pharmacology & Therapeutics 46:7, pages 704-705.
Crossref
A. Aksan, H. Işık, H. H. Radeke, A. Dignass & J. Stein. (2017) Editorial: which iron preparation for patients with IBD ? Authors’ reply . Alimentary Pharmacology & Therapeutics 46:2, pages 195-196.
Crossref
N. A. Kennedy, J. R. Goodhand & D. S. Rampton. (2017) Editorial: which iron preparation for patients with IBD?. Alimentary Pharmacology & Therapeutics 46:2, pages 194-195.
Crossref
A. Aksan, H. Işık, H. H. Radeke, A. Dignass & J. Stein. (2017) Systematic review with network meta‐analysis: comparative efficacy and tolerability of different intravenous iron formulations for the treatment of iron deficiency anaemia in patients with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 45:10, pages 1303-1318.
Crossref
Svein Oskar Frigstad, Anne Haaber, Antal Bajor, Jan Fallingborg, Per Hammarlund, Ole K. Bonderup, Håkan Blom, Terje Rannem & Per M. Hellström. (2017) The NIMO Scandinavian Study: A Prospective Observational Study of Iron Isomaltoside Treatment in Patients with Iron Deficiency. Gastroenterology Research and Practice 2017, pages 1-7.
Crossref
A. Poscia, J. Stojanovic, F. Kheiraoui, E. M. Proli, F. Scaldaferri, M. Volpe, M. L. Di Pietro, A. Gasbarrini, L. Fabrizio, S. Boccia & C. Favaretti. (2017) Sustainability of Endovenous Iron Deficiency Anaemia Treatment: Hospital-Based Health Technology Assessment in IBD Patients. BioMed Research International 2017, pages 1-9.
Crossref
Roberta E. Rossi, Tara Whyand, Charles D. Murray, Mark I. Hamilton, Dario Conte & Martyn E. Caplin. (2016) The role of dietary supplements in inflammatory bowel disease: a systematic review. European Journal of Gastroenterology & Hepatology 28:12, pages 1357-1364.
Crossref
Istvan Danko & Marcy Weidkamp. (2016) Correction of Iron Deficiency Anemia With Intravenous Iron Sucrose in Children With Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition 63:5.
Crossref
Ersilia M. DeFilippis, Robbyn Sockolow & Elaine Barfield. (2016) Health Care Maintenance for the Pediatric Patient With Inflammatory Bowel Disease. Pediatrics 138:3.
Crossref
C. Schmidt, T. Ahmad, Z. Tulassay, D. C. Baumgart, B. Bokemeyer, S. Howaldt, A. Stallmach & C. Büning. (2016) Ferric maltol therapy for iron deficiency anaemia in patients with inflammatory bowel disease: long‐term extension data from a Phase 3 study. Alimentary Pharmacology & Therapeutics 44:3, pages 259-270.
Crossref
Yoo Min Han, Hyuk Yoon, Cheol Min Shin, Seong-Joon Koh, Jong Pil Im, Byeong Gwan Kim, Joo Sung Kim & Hyun Chae Jung. (2016) Comparison of the Efficacies of Parenteral Iron Sucrose and Oral Iron Sulfate for Anemic Patients with Inflammatory Bowel Disease in Korea. Gut and Liver 10:4, pages 562-568.
Crossref
Ben Clevenger, Kurinchi Gurusamy, Andrew A. Klein, Gavin J. Murphy, Stefan D. Anker & Toby Richards. (2016) Systematic review and meta‐analysis of iron therapy in anaemic adults without chronic kidney disease: updated and abridged Cochrane review. European Journal of Heart Failure 18:7, pages 774-785.
Crossref
Natalia Murawska, Adam Fabisiak & Jakub Fichna. (2016) Anemia of Chronic Disease and Iron Deficiency Anemia in Inflammatory Bowel Diseases. Inflammatory Bowel Diseases 22:5, pages 1198-1208.
Crossref
Torbjörn Karlsson & Honar Cherif. (2016) Effect of Intravenous Iron Supplementation on Iron Stores in Non-Anemic Iron-Deficient Patients with Hereditary Hemorrhagic Telangiectasia. Hematology Reports 8:1, pages 6348.
Crossref
Pramoda Koduru & Bincy P. Abraham. (2015) The role of ferric carboxymaltose in the treatment of iron deficiency anemia in patients with gastrointestinal disease. Therapeutic Advances in Gastroenterology 9:1, pages 76-85.
Crossref
Stefanos Bonovas, Gionata Fiorino, Mariangela Allocca, Theodore Lytras, Argirios Tsantes, Laurent Peyrin-Biroulet & Silvio Danese. (2016) Intravenous Versus Oral Iron for the Treatment of Anemia in Inflammatory Bowel Disease. Medicine 95:2, pages e2308.
Crossref
Jenny Sauk. 2016. Nutritional Management of Inflammatory Bowel Diseases. Nutritional Management of Inflammatory Bowel Diseases 3 16 .
Roni Weisshof & Irit Chermesh. (2015) Micronutrient deficiencies in inflammatory bowel disease. Current Opinion in Clinical Nutrition and Metabolic Care 18:6, pages 576-581.
Crossref
João Ricardo Friedrisch & Rodolfo Delfini Cançado. (2015) Intravenous ferric carboxymaltose for the treatment of iron deficiency anemia. Revista Brasileira de Hematologia e Hemoterapia 37:6, pages 400-405.
Crossref
Anita Abhyankar & Alan C. Moss. (2015) Iron Replacement in Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases 21:8, pages 1976-1981.
Crossref
Ole Haagen Nielsen, Mark Ainsworth, Mehmet Coskun & Günter Weiss. (2015) Management of Iron-Deficiency Anemia in Inflammatory Bowel Disease. Medicine 94:23, pages e963.
Crossref
Tariq Iqbal, Jürgen Stein, Naveen Sharma, Stefanie Kulnigg-Dabsch, Senthil Vel & Christoph Gasche. (2014) Clinical Significance of C-Reactive Protein Levels in Predicting Responsiveness to Iron Therapy in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia. Digestive Diseases and Sciences 60:5, pages 1375-1381.
Crossref
Christoph Gasche, Tariq Ahmad, Zsolt Tulassay, Daniel C. Baumgart, Bernd Bokemeyer, Carsten Büning, Stefanie Howaldt & Andreas Stallmach. (2015) Ferric Maltol Is Effective in Correcting Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases 21:3, pages 579-588.
Crossref
Axel U DignassChristoph GascheDominik Bettenworth, Gunnar Birgegård, Silvio Danese, Javier P Gisbert, Fernando Gomollon, Tariq Iqbal, Konstantinos Katsanos, Ioannis Koutroubakis, Fernando Magro, Guillaume Savoye, Jürgen Stein & Stephan Vavricka. (2015) European Consensus on the Diagnosis and Management of Iron Deficiency and Anaemia in Inflammatory Bowel Diseases. Journal of Crohn's and Colitis 9:3, pages 211-222.
Crossref
Zoe Tolkien, Lynne Stecher, Adrian P. Mander, Dora I. A. Pereira & Jonathan J. Powell. (2015) Ferrous Sulfate Supplementation Causes Significant Gastrointestinal Side-Effects in Adults: A Systematic Review and Meta-Analysis. PLOS ONE 10:2, pages e0117383.
Crossref
Hui Sian Tay & Roy L. Soiza. (2015) Systematic Review and Meta-Analysis: What Is the Evidence for Oral Iron Supplementation in Treating Anaemia in Elderly People?. Drugs & Aging 32:2, pages 149-158.
Crossref
Gerhard Rogler & Stephan Vavricka. (2015) Anemia in Inflammatory Bowel Disease: An Under-Estimated Problem?. Frontiers in Medicine 1.
Crossref
S. Hardy & X. Vandemergel. (2015) Intravenous Iron Administration and Hypophosphatemia in Clinical Practice. International Journal of Rheumatology 2015, pages 1-6.
Crossref
B. Clevenger & T. Richards. (2014) Pre‐operative anaemia. Anaesthesia 70:s1, pages 20.
Crossref
G. van Assche, A. Dignass, B. Bokemeyer, S. Danese, P. Gionchetti, G. Moser, L. Beaugerie, F. Gomollón, W. Häuser, K. Herrlinger, B. Oldenburg, J. Panes, F. Portela, G. Rogler, J. Stein, H. Tilg, S. Travis & J.O. Lindsay. (2015) Segundo consenso europeo basado en evidencia sobre el diagnóstico y tratamiento de la colitis ulcerosa crónica idiopática. Parte 3: situaciones especiales (versión española). Revista de Gastroenterología de México 80:1, pages 74-106.
Crossref
Tomer Avni, Amir Bieber, Alon Grossman, Hefziba Green, Leonard Leibovici & Anat Gafter-Gvili. (2015) The Safety of Intravenous Iron Preparations. Mayo Clinic Proceedings 90:1, pages 12-23.
Crossref
Kurinchi Selvan Gurusamy, Myura Nagendran, Jack F Broadhurst, Stefan D Anker & Toby Richards. (2014) Iron therapy in anaemic adults without chronic kidney disease. Cochrane Database of Systematic Reviews 2014:12.
Crossref
Daniel Sjöberg, Tommy Holmström, Märit Larsson, Anne-Lie Nielsen, Lars Holmquist & Anders Rönnblom. (2014) Anemia in a Population-based IBD Cohort (ICURE). Inflammatory Bowel Diseases 20:12, pages 2266-2270.
Crossref
Jonathan J. Powell, Sylvaine F.A. Bruggraber, Nuno Faria, Lynsey K. Poots, Nicole Hondow, Timothy J. Pennycook, Gladys O. Latunde-Dada, Robert J. Simpson, Andy P. Brown & Dora I.A. Pereira. (2014) A nano-disperse ferritin-core mimetic that efficiently corrects anemia without luminal iron redox activity. Nanomedicine: Nanotechnology, Biology and Medicine 10:7, pages 1529-1538.
Crossref
Irina Blumenstein, Axel Dignass, Stephan Vollmer, Wolfgang Klemm, Susanne Weber-Mangal & Juergen Stein. (2014) Current practice in the diagnosis and management of IBD-associated anaemia and iron deficiency in Germany: The German AnaemIBD Study. Journal of Crohn's and Colitis 8:10, pages 1308-1314.
Crossref
Sebastian Lugg, Felicity Beal, Peter Nightingale, Neeraj Bhala & Tariq Iqbal. (2014) Iron treatment and inflammatory bowel disease: What happens in real practice?. Journal of Crohn's and Colitis 8:8, pages 876-880.
Crossref
Martyn Dibb & Sreedhar Subramanian. (2014) Anaemia in inflammatory bowel disease. Frontline Gastroenterology 5:3, pages 190-196.
Crossref
. (2014) Control disease activity and correct iron deficit when iron-deficiency anaemia occurs in patients with inflammatory bowel disease. Drugs & Therapy Perspectives 30:6, pages 209-212.
Crossref
Jason R. Goldsmith & R. Balfour Sartor. (2014) The role of diet on intestinal microbiota metabolism: downstream impacts on host immune function and health, and therapeutic implications. Journal of Gastroenterology 49:5, pages 785-798.
Crossref
P. Bager & J. F. Dahlerup. (2013) Randomised clinical trial: oral vs. intravenous iron after upper gastrointestinal haemorrhage – a placebo‐controlled study. Alimentary Pharmacology & Therapeutics 39:2, pages 176-187.
Crossref
Tomer Avni, Amir Bieber, Tali Steinmetz, Leonard Leibovici & Anat Gafter-Gvili. (2013) Treatment of Anemia in Inflammatory Bowel Disease– Systematic Review and Meta-Analysis. PLoS ONE 8:12, pages e75540.
Crossref
Walter Reinisch, Michael Staun, Rakesh K Tandon, Istvan Altorjay, Andrew V Thillainayagam, Cornelia Gratzer, Sandeep Nijhawan & Lars L Thomsen. (2013) A Randomized, Open-Label, Non-Inferiority Study of Intravenous Iron Isomaltoside 1,000 (Monofer) Compared With Oral Iron for Treatment of Anemia in IBD (PROCEED). American Journal of Gastroenterology 108:12, pages 1877-1888.
Crossref
Fernando Gomollón & Javier P. Gisbert. (2013) Current Management of Iron Deficiency Anemia in Inflammatory Bowel Diseases: A Practical Guide. Drugs 73:16, pages 1761-1770.
Crossref
S.R. Leal-Noval, M. Muñoz, M. Asuero, E. Contreras, J.A. García-Erce, J.V. Llau, V. Moral, J.A. Páramo, M. Quintana, M. Basora, F.J. Bautista-Paloma, E. Bisbe, J.L. Bóveda, A. Castillo-Muñoz, M.J. Colomina, C. Fernández, E. Fernández-Mondéjar, C. Ferrándiz, A. García de Lorenzo, C. Gomar, A. Gómez-Luque, M. Izuel, V. Jiménez-Yuste, E. López-Briz, M.L. López-Fernández, J.A. Martín-Conde, B. Montoro-Ronsano, C. Paniagua, J.A. Romero-Garrido, J.C. Ruiz, R. Salinas-Argente, C. Sánchez, P. Torrabadella, V. Arellano, A. Candela, J.A. Fernández, E. Fernández-Hinojosa & A. Puppo. (2013) 2013. Documento Sevilla de Consenso sobre Alternativas a la Transfusión de Sangre Alogénica. Actualización del Documento Sevilla. Revista Española de Anestesiología y Reanimación 60:5, pages 263.e1-263.e25.
Crossref
S.R. Leal-Noval, M. Muñoz, M. Asuero, E. Contreras, J.A. García-Erce, J.V. Llau, V. Moral, J.A. Páramo, M. Quintana, M. Basora, F.J. Bautista-Paloma, E. Bisbe, J.L. Bóveda, A. Castillo-Muñoz, M.J. Colomina, C. Fernández, E. Fernández-Mondéjar, C. Ferrándiz, A. García de Lorenzo, C. Gomar, A. Gómez-Luque, M. Izuel, V. Jiménez-Yuste, E. López-Briz, M.L. López-Fernández, J.A. Martín-Conde, B. Montoro-Ronsano, C. Paniagua, J.A. Romero-Garrido, J.C. Ruiz, R. Salinas-Argente, C. Sánchez, P. Torrabadella, V. Arellano, A. Candela, J.A. Fernández, E. Fernández-Hinojosa & A. Puppo. (2013) 2013. Documento Sevilla de Consenso sobre Alternativas a la Transfusión de Sangre Alogénica. Actualización del Documento Sevilla. Medicina Intensiva 37:4, pages 259-283.
Crossref
Fernando Gomollón & Javier P. Gisbert. (2013) Intravenous iron in inflammatory bowel diseases. Current Opinion in Gastroenterology 29:2, pages 201-207.
Crossref
Rayko Evstatiev, Olga Alexeeva, Bernd Bokemeyer, Ivan Chopey, Marcel Felder, Maja Gudehus, Tariq Iqbal, Igor Khalif, Philippe Marteau, Jürgen Stein & Christoph Gasche. (2013) Ferric Carboxymaltose Prevents Recurrence of Anemia in Patients With Inflammatory Bowel Disease. Clinical Gastroenterology and Hepatology 11:3, pages 269-277.
Crossref
Gert Van Assche, Axel Dignass, Bernd Bokemeyer, Silvio Danese, Paolo Gionchetti, Gabriele Moser, Laurent Beaugerie, Fernando Gomollón, Winfried Häuser, Klaus Herrlinger, Bas Oldenburg, Julian Panes, Francisco Portela, Gerhard Rogler, Jürgen Stein, Herbert Tilg, Simon Travis & James O. Lindsay. (2013) Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 3: Special situations. Journal of Crohn's and Colitis 7:1, pages 1-33.
Crossref
Jonathan J Powell, William B Cook, Carol Hutchinson, Zoe Tolkien, Mark Chatfield, Dora IA Pereira & Miranda CE Lomer. (2013) Dietary fortificant iron intake is negatively associated with quality of life in patients with mildly active inflammatory bowel disease. Nutrition & Metabolism 10:1, pages 9.
Crossref
FERNANDO GOMOLLÓN & JAVIER P. GISBERT. (2012) Intravenous iron in digestive diseases. Transfusion Alternatives in Transfusion Medicine 12:3-4, pages 122-129.
Crossref
Saurabh Kumar Gupta, Anita Saxena, Om Murty Anil & Akshay Kumar Bisoi. (2012) Thrombus in Right Ventricular Outflow Tract: Unique Cause of Refractory Cyanotic Spell. Congenital Heart Disease 7:4, pages E56-E58.
Crossref
Sumera Rizvi & Robert E Schoen. (2012) Response to Michael. American Journal of Gastroenterology 107:6, pages 950-951.
Crossref
Tim J. Littlewood. (2011) Intravenous or oral iron?. American Journal of Hematology 87:2, pages 134-135.
Crossref
Claudia Ott, Anne Liebold, Angela Takses, Ulrike G. Strauch & Florian Obermeier. (2012) High Prevalence but Insufficient Treatment of Iron-Deficiency Anemia in Patients with Inflammatory Bowel Disease: Results of a Population-Based Cohort. Gastroenterology Research and Practice 2012, pages 1-7.
Crossref
Sumera Rizvi & Robert E Schoen. (2011) Supplementation With Oral vs. Intravenous Iron for Anemia With IBD or Gastrointestinal Bleeding: Is Oral Iron Getting a Bad Rap?. American Journal of Gastroenterology 106:11, pages 1872-1879.
Crossref
Hermann Schulze & Axel Dignass. 2011. Clinical Dilemmas in Inflammatory Bowel Disease. Clinical Dilemmas in Inflammatory Bowel Disease 237 240 .
Rayko Evstatiev, Philippe Marteau, Tariq Iqbal, Igor L. Khalif, Jürgen Stein, Bernd Bokemeyer, Ivan V. Chopey, Florian S. Gutzwiller, Lise Riopel & Christoph Gasche. (2011) FERGIcor, a Randomized Controlled Trial on Ferric Carboxymaltose for Iron Deficiency Anemia in Inflammatory Bowel Disease. Gastroenterology 141:3, pages 846-853.e2.
Crossref
Jürgen Stein, Franz Hartmann & Axel U. Dignass. (2010) Diagnosis and management of iron deficiency anemia in patients with IBD. Nature Reviews Gastroenterology & Hepatology 7:11, pages 599-610.
Crossref
Palle Bager & Jens F. Dahlerup. (2010) The health care cost of intravenous iron treatment in IBD patients depends on the economic evaluation perspective. Journal of Crohn's and Colitis 4:4, pages 427-430.
Crossref
Fernando GomollónJavier P. Gisbert & José Antonio García-Erce. (2010) Intravenous iron in digestive diseases: a clinical (re)view. Therapeutic Advances in Chronic Disease 1:2, pages 67-75.
Crossref
Amy Zhu, Marc Kaneshiro & Jonathan D. Kaunitz. (2010) Evaluation and Treatment of Iron Deficiency Anemia: A Gastroenterological Perspective. Digestive Diseases and Sciences 55:3, pages 548-559.
Crossref
Manuel Muñoz, Susana Gómez-Ramírez & José Antonio García-Erce. (2009) Intravenous iron in inflammatory bowel disease. World Journal of Gastroenterology 15:37, pages 4666.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.